85 related articles for article (PubMed ID: 1946090)
21. Natural killer T cells: a bridge to tolerance or a pathway to rejection?
Jukes JP; Wood KJ; Jones ND
Transplantation; 2007 Sep; 84(6):679-81. PubMed ID: 17893598
[TBL] [Abstract][Full Text] [Related]
22. [Mechanism of secondary allograft rejection: appearance of killer T cells at the site of allograft rejection (author's transl)].
Nanishi F
Fukuoka Igaku Zasshi; 1980 Sep; 71(9):504-20. PubMed ID: 7450661
[No Abstract] [Full Text] [Related]
23. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
[TBL] [Abstract][Full Text] [Related]
24. [Stem cell inactivation by allogenic lymphocytes: characteristics of suppressor cells blocking the killer action of syngeneic lymphocytes].
Ignat'eva GA; Man'ko VM; Dishkant IP
Tsitologiia; 1981 Dec; 23(12):1386-94. PubMed ID: 6460363
[TBL] [Abstract][Full Text] [Related]
25. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
Peres A; Nestel FP; Seemayer TA; Lapp WS
J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
[TBL] [Abstract][Full Text] [Related]
26. Role of natural killer and killer cells in concordant xenograft rejection.
Patselas T; Thomas F; Araneda D; Marchman W
Transplant Proc; 1995 Feb; 27(1):262-3. PubMed ID: 7878995
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapeutic aspects of allogeneic peripheral progenitor cells.
Glass B; Uharek L; Hartung G; Zeis M; Steinmann J; Dreger P; Krönke M; Schmitz N
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S3-8. PubMed ID: 9712483
[TBL] [Abstract][Full Text] [Related]
28. Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice.
Nagata S; Okano S; Yonemitsu Y; Nakagawa K; Tomita Y; Yoshikai Y; Shimada M; Maehara Y; Sueishi K
Transplantation; 2006 Sep; 82(5):689-98. PubMed ID: 16969294
[TBL] [Abstract][Full Text] [Related]
29. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells.
Street SE; Hayakawa Y; Zhan Y; Lew AM; MacGregor D; Jamieson AM; Diefenbach A; Yagita H; Godfrey DI; Smyth MJ
J Exp Med; 2004 Mar; 199(6):879-84. PubMed ID: 15007091
[TBL] [Abstract][Full Text] [Related]
30. Acute rejection of marrow grafts in mice. Dependence on and independence of functional TCR in the rejection process.
Takeda K; Moore MW; Dennert G
J Immunol; 1994 May; 152(9):4407-16. PubMed ID: 8157961
[TBL] [Abstract][Full Text] [Related]
31. Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients.
Sykes M; Chester CH; Sundt TM; Romick ML; Hoyles KA; Sachs DH
J Immunol; 1989 Dec; 143(11):3503-11. PubMed ID: 2584703
[TBL] [Abstract][Full Text] [Related]
32. An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells.
Murphy WJ; Kumar V; Cope JC; Bennett M
J Immunol; 1990 May; 144(9):3305-11. PubMed ID: 2329274
[TBL] [Abstract][Full Text] [Related]
33. Perforin- and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice.
Baker MB; Podack ER; Levy RB
Biol Blood Marrow Transplant; 1995 Dec; 1(2):69-73. PubMed ID: 9118294
[TBL] [Abstract][Full Text] [Related]
34. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
[TBL] [Abstract][Full Text] [Related]
35. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
36. Suppressor cells and loss of in vitro killer cell inductiveness to donor cells in the peripheral blood lymphocytes of allograft recipients.
Dossetor JB; Liburd EM; Kovithavongs T; Pazderka V
Transplant Proc; 1979 Jun; 11(2):1260-2. PubMed ID: 157569
[No Abstract] [Full Text] [Related]
37. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
Zeis M; Uharek L; Glass B; Gaska T; Gassmann W; Mueller-Ruchholtz W
Bone Marrow Transplant; 1994 Nov; 14(5):711-5. PubMed ID: 7889004
[TBL] [Abstract][Full Text] [Related]
38. Hybrid and allogeneic resistance to T cell grafts mediated by murine NK and CD8+ T cells.
Davenport C; Haile A; Kumar V; Bennett M
J Immunol; 1995 Mar; 154(6):2568-77. PubMed ID: 7876533
[TBL] [Abstract][Full Text] [Related]
39. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
40. Phenotyping of ex vivo propagated graft-infiltrating cells-a tool to monitor rejection in the early post-operative period.
Johnsson C; Lorant T; Quach M; Tufveson G
Transpl Immunol; 2006 Aug; 16(2):81-7. PubMed ID: 16860709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
